Gene · 8324
Papers1,967
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,967
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In vitro and Pharmacoinformatics-based phytochemical screening for anticancer impacts of pistachio hull essential oil on AGS, PLC/PRF/5, and CACO2 cell lines. | Mol Biol Rep | 2023 | 36348196 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| ΔNp63α in cancer: importance and therapeutic opportunities. | Trends Cell Biol | 2023 | 36115734 | PubTator, text mining | PubMed |
| Recombinant human chorionic gonadotropin induces signaling pathways towards cancer prevention in the breast of BRCA1/2 mutation carriers. | Eur J Cancer Prev | 2023 | 35881946 | PubTator, text mining | PubMed |
| Identification of Ferroptosis-related molecular model and immune subtypes of hepatocellular carcinoma for individual therapy. | Cancer Med | 2023 | 35841206 | PubTator, text mining | PubMed |
| Wnt signaling in liver regeneration, disease, and cancer. | Clin Mol Hepatol | 2023 | 35785913 | PubTator, text mining | PubMed |
| Correction to: cRel and Wnt5a/Frizzled 5 Receptor-Mediated Inflammatory Regulation Reveal Novel Neuroprotectin D1 Targets for Neuroprotection. | Cell Mol Neurobiol | 2023 | 35759137 | PubTator, text mining | PubMed |
| cRel and Wnt5a/Frizzled 5 Receptor-Mediated Inflammatory Regulation Reveal Novel Neuroprotectin D1 Targets for Neuroprotection. | Cell Mol Neurobiol | 2023 | 35622188 | PubTator, text mining | PubMed |
| Zinc oxide nanoparticles inhibit osteosarcoma metastasis by downregulating β-catenin via HIF-1α/BNIP3/LC3B-mediated mitophagy pathway. | Bioact Mater | 2023 | 35600978 | PubTator, text mining | PubMed |
| Coumarin derivative as a potent drug candidate against triple negative breast cancer targeting the frizzled receptor of wingless-related integration site signaling pathway. | J Biomol Struct Dyn | 2023 | 34984961 | PubTator, text mining | PubMed |
| Circular RNAs: Biomarkers of cancer. | Cancer Innov | 2022 | 38089761 | PubTator, text mining | PubMed |
| Exosomes as Neurological Nanosized Machines. | ACS Nanosci Au | 2022 | 37102062 | PubTator, text mining | PubMed |
| The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand-dependent Cancer Models. | Cancer Res Commun | 2022 | 36922934 | PubTator, text mining | PubMed |
| Integration of single-cell RNA sequencing and spatial transcriptomics to reveal the glioblastoma heterogeneity. | F1000Res | 2022 | 36875988 | PubTator, text mining | PubMed |
| Wnt signaling pathway-derived score for predicting therapeutic resistance and tumor microenvironment in lung adenocarcinoma. | Front Pharmacol | 2022 | 36703749 | PubTator, text mining | PubMed |
| Identification of therapeutic targets and prognostic biomarkers among frizzled family genes in glioma. | Front Mol Biosci | 2022 | 36699699 | PubTator, text mining | PubMed |
| Amoeboid migration in health and disease: Immune responses versus cancer dissemination. | Front Cell Dev Biol | 2022 | 36699013 | PubTator, text mining | PubMed |
| Identification and validation of signature for prognosis and immune microenvironment in gastric cancer based on m6A demethylase ALKBH5. | Front Oncol | 2022 | 36686788 | PubTator, text mining | PubMed |
| Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinoma. | Front Genet | 2022 | 36685852 | PubTator, text mining | PubMed |
| Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer. | Ann Transl Med | 2022 | 36660722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8324/papers?page=16